From Casetext: Smarter Legal Research

Bisel v. Acasti Pharma, Inc.

United States District Court, S.D. New York
Sep 28, 2022
21 CIVIL 6051 (KPF) (S.D.N.Y. Sep. 28, 2022)

Opinion

21 CIVIL 6051 (KPF)

09-28-2022

LAUDEN BISEL, Individually and on Behalf of All Others Similarly Situated, Plaintiff, v. ACASTI PHARMA, INC., RODERICK CARTER, JAN D'ALVISE, JOHN CANAN, and DONALD OLDS, Defendants.


JUDGMENT

It is hereby ORDERED, ADJUDGED AND DECREED: That for the reasons stated in the Court's Opinion and Order dated September 28, 2022, the Court has GRANTED the Defendants' motion to dismiss in full. Further, because Plaintiff has already amended his pleadings twice, and because he has given no indication that he can amend them further to plead viable claims indeed his former counsel represented to the Court that they could "no longer reasonably oppose the Motion to Dismiss" (Dkt. ¶ #35 8) the Court will not grant leave to amend; accordingly, case No. 21 Civ. 6051 and case No. 21 Civ. 6567, which was previously consolidated with this case, are closed.


Summaries of

Bisel v. Acasti Pharma, Inc.

United States District Court, S.D. New York
Sep 28, 2022
21 CIVIL 6051 (KPF) (S.D.N.Y. Sep. 28, 2022)
Case details for

Bisel v. Acasti Pharma, Inc.

Case Details

Full title:LAUDEN BISEL, Individually and on Behalf of All Others Similarly Situated…

Court:United States District Court, S.D. New York

Date published: Sep 28, 2022

Citations

21 CIVIL 6051 (KPF) (S.D.N.Y. Sep. 28, 2022)